NASDAQ:RLMD

Relmada Therapeutics Earnings Date, Estimates & Call Transcripts (2022)

$18.30

-0.69 (-3.63%)

(As of 07/1/2022 12:00 AM ET)

Add

Compare

Today's Range: $18.25
▼
$18.99
50-Day Range: $16.50
▼
$25.87
52-Week Range: $15.73
▼
$35.35

Volume: 281,933 shs
Average Volume: 278,689 shs
Market Capitalization: $548.84 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $46.71

Upcoming Earnings Date: Aug. 9Estimated
Actual EPS (May. 5): -$1.40 Missed By -$0.19
Consensus EPS (May. 5): -$1.21
Last Year's Q2 EPS (5/12/2021): -$1.34

Earnings Per Share Revenue

RLMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RLMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Relmada Therapeutics Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2022	2	($1.26)	($1.24)	($1.25)
Q2 2022	3	($1.30)	($1.28)	($1.29)
Q3 2022	3	($1.36)	($1.31)	($1.33)
Q4 2022	3	($1.40)	($1.35)	($1.38)
FY 2022	11	($5.32)	($5.18)	($5.24)
Q1 2023	1	($1.45)	($1.45)	($1.45)
Q2 2023	1	($1.41)	($1.41)	($1.41)
Q3 2023	1	($1.32)	($1.32)	($1.32)
Q4 2023	1	($1.49)	($1.49)	($1.49)
FY 2023	4	($5.67)	($5.67)	($5.67)

RLMD Earnings Date and Information

Relmada Therapeutics last announced its earnings results on May 5th, 2022. The reported ($1.40) earnings per share for the quarter, missing the consensus estimate of ($1.21) by $0.19. Relmada Therapeutics has generated ($7.20) earnings per share over the last year (($7.20) diluted earnings per share). Earnings for Relmada Therapeutics are expected to grow in the coming year, from ($5.41) to ($3.82) per share. Relmada Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 9th, 2022 based off prior year's report dates.

Relmada Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS
8/9/2022 (Estimated)
5/5/2022	Q1 2022	($1.21)	($1.40)	($0.19)	($1.40)
3/23/2022	Q4 2021	($1.60)	($1.80)	($0.20)	($1.80)
11/11/2021	9/30/2021	($1.62)	($2.44)	($0.82)	($2.44)
8/10/2021	6/30/2021	($1.47)	($1.56)	($0.09)	($1.56)
5/12/2021	3/31/2021	($1.38)	($1.34)	+$0.04	($1.34)
3/22/2021	12/31/2020	($1.11)	($1.31)	($0.20)	($1.28)
11/12/2020	Q3 2020		($1.05)	($1.05)	($1.05)
8/12/2020	Q2 2020	($0.55)	($0.73)	($0.18)	($0.73)
8/12/2020	Q2 2020	($0.55)	($0.73)	($0.18)	($0.73)
8/12/2020	Q2 2020	($0.55)	($0.73)	($0.18)	($0.73)

5/15/2020	Q1 2020	($0.33)	($0.72)	($0.39)	($0.72)
5/15/2020	Q1 2020	($0.33)	($0.72)	($0.39)	($0.72)
5/15/2020	Q1 2020	($0.33)	($0.72)	($0.39)	($0.72)
11/13/2019	Q3 2019		($0.38)	($0.38)	($0.38)
11/13/2019	Q1 2020		($0.38)	($0.38)	($0.38)
11/13/2019	Q1 2020		($0.38)	($0.38)	($0.38)
9/24/2019	Q2 2019		($0.44)	($0.44)	($0.44)
9/24/2019	Q4 2019		($0.44)	($0.44)	($0.44)
9/24/2019	Q4 2019		($0.44)	($0.44)	($0.44)
5/14/2019	Q1 2019		($0.36)	($0.36)	($0.36)
5/14/2019	Q3 2019		($0.36)	($0.36)	($0.36)
5/14/2019	Q3 2019		($0.09)	($0.09)	($0.09)
2/13/2019	Q4 2018		($1.12)	($1.12)	($1.12)
2/13/2019	Q2 2019		($1.12)	($1.12)	($1.12)
2/13/2019	Q2 2019		($0.28)	($0.28)	($0.28)
11/13/2018	Q3 2018		($1.08)	($1.08)	($1.08)
11/13/2018	Q1 2019		($1.08)	($1.08)	($1.08)
11/13/2018	Q1 2019		($0.27)	($0.27)	($0.27)
5/14/2018	Q1 2018		($1.04)	($1.04)	($1.04)
5/14/2018	Q3 2018		($1.04)	($1.04)	($1.04)
5/14/2018	Q3 2018		($0.26)	($0.26)	($0.26)
2/12/2018	Q4 2017		($0.44)	($0.44)	($0.44)
2/12/2018	Q2 2018		($0.44)	($0.44)	($0.44)
2/12/2018	Q2 2018		($0.11)	($0.11)	($0.11)
11/14/2017	Q3 2017		($0.32)	($0.32)	($0.32)
11/14/2017	Q1 2018		($0.32)	($0.32)	($0.32)
11/14/2017	Q1 2018		($0.08)	($0.08)	($0.08)
9/28/2017	Q2 2017		($0.52)	($0.52)	($0.52)
9/28/2017	Q4 2017		($0.52)	($0.52)	($0.52)
9/28/2017	Q4 2017		($0.13)	($0.13)	($0.13)
5/15/2017	Q1 2017		($0.64)	($0.64)	($0.64)
5/15/2017	Q3 2017		($0.64)	($0.64)	($0.64)
5/15/2017	Q3 2017		($0.16)	($0.16)	($0.16)
2/10/2017	Q4 2016		($0.36)	($0.36)	($0.36)
2/10/2017	Q2 2017		($0.36)	($0.36)	($0.36)
2/10/2017	Q2 2017		($0.09)	($0.09)	($0.09)
11/10/2016	Q3 2016		($0.56)	($0.56)	($0.56)
11/10/2016	Q1 2017		($0.56)	($0.56)	($0.56)
11/10/2016	Q1 2017		($0.14)	($0.14)	($0.14)
9/9/2016	Q2 2016	($0.72)	($1.16)	($0.44)	($1.16)
9/9/2016	Q4 2016	($0.72)	($1.16)	($0.44)	($1.16)
9/9/2016	Q4 2016	($0.18)	($0.29)	($0.11)	($0.29)
5/9/2016	Q1 2016	($1.56)	($0.60)	+$0.96	($0.60)
5/9/2016	Q3 2016	($1.56)	($0.60)	+$0.96	($0.60)
5/9/2016	Q3 2016	($0.39)	($0.15)	+$0.24	($0.15)
2/5/2016	Q4 2015	($1.68)	($0.88)	+$0.80	($0.88)
2/5/2016	Q2 2016	($1.68)	($0.88)	+$0.80	($0.88)
2/5/2016	Q2 2016	($0.42)	($0.22)	+$0.20	($0.22)
11/6/2015	Q3 2015		$1.44	+$1.44	$1.44
11/6/2015	Q1 2016		$1.44	+$1.44	$1.44
11/6/2015	Q1 2016		$0.36	+$0.36	$0.36
5/15/2015	Q2 2015		($0.20)	($0.20)	($0.20)
5/15/2015	Q4 2015		($0.20)	($0.20)	($0.20)
5/15/2015	Q4 2015		($0.05)	($0.05)	($0.05)

Relmada Therapeutics Earnings - Frequently Asked Questions

When is Relmada Therapeutics's earnings date?: Relmada Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 9th, 2022 based off last year's report dates. Learn more on RLMD's earnings history.
Did Relmada Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Relmada Therapeutics (NASDAQ:RLMD) missed the analysts' consensus estimate of ($1.21) by $0.19 with a reported earnings per share (EPS) of ($1.40). Learn more on analysts' earnings estimate vs. RLMD's actual earnings.

How much profit does Relmada Therapeutics generate each year?: Relmada Therapeutics (NASDAQ:RLMD) has a recorded net income of -$125.75 million. RLMD has generated -$7.20 earnings per share over the last four quarters.
What is Relmada Therapeutics's EPS forecast for next year?: Relmada Therapeutics's earnings are expected to grow from ($5.41) per share to ($3.82) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

PepsiCo (7/12/2022)
América Móvil (7/12/2022)
Infosys (7/13/2022)
Morgan Stanley (7/14/2022)
Taiwan Semiconductor Manufacturing (7/14/2022)
JPMorgan Chase & Co. (7/14/2022)
Wells Fargo (7/15/2022)
U.S. Bancorp (7/15/2022)
Citigroup (7/15/2022)
HDFC Bank (7/15/2022)

This page (NASDAQ:RLMD) was last updated on 7/2/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources